[Kaposi disease in an LAV/HTLV-III antibody negative patient at risk for AIDS] NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Kaposi disease in an LAV/HTLV-III antibody negative patient at risk for AIDS]

Z Hautkr. 1987 Nov 15;62(22):1603-14. Unique Identifier : AIDSLINE MED/88128939
Oehlschlaegel G; Marquart KH; Engst R; Dermatologische Klinik und Poliklinik der Technischen; Universitat Munchen.

Abstract: We report on a disseminated variant of Kaposi's sarcoma (M.K.) with a moderate course in a homosexual patient negative for LAV/HTLV-III antibodies. The disease had started at the age of 44 years. Clinical examination proved the patient's good condition. Serological findings revealed numerous former infections. Control investigations for 5 years have not shown any signs of immune deficiency, so far. Morphological investigation (applicable to all forms of M.K.) indicated a reversed differentiation of the vascular connective tissue with ensuing misdifferentiation. Thus, the tumor should be interpreted as an abnormal product of the primary vascular mesenchyme. It is characterized by a synchymal/spongiochymal structure. This view corresponds with older ideas. Recent histochemical and electron microscopical findings do not contradict this conception in any way, but do rather confirm it.
Keywords: Acquired Immunodeficiency Syndrome/*PATHOLOGY Case Report Endothelium, Vascular/PATHOLOGY English Abstract Homosexuality Human *HIV Seropositivity Male Microscopy, Electron Middle Age Penile Neoplasms/*PATHOLOGY Risk Factors Sarcoma, Kaposi's/*PATHOLOGY Skin/PATHOLOGY JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDpathologycasereportendothelium,vascular/pathologyenglishabstracthomosexualityhumanKWDhivseropositivitymalemicroscopy,electronmiddleagepenileneoplasms/KWDpathologyriskfactorssarcoma,kaposi's/KWDpathologyskin/pathologyjournalarticle
880530
M8850397

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .